Prospective Studies are Required to Assess the Prevalence/Incidence of Neuro-Covid
DOI:
https://doi.org/10.47363/JMHC/2021(3)153Keywords:
SARS-CoV-2, COVID-19, Neurological, Nerves, NeuropathyAbstract
With interest we read the article by Khedr et al. about a retrospective cohort study of 117 patients with neuro-COVID collected during a three months period in Upper Egypt [1]. It was found that stroke was the most frequent central nervous system (CNS) manifestation of neuro-COVID in this cohort and that anosmia/ageusia was the most frequent peripheral nervous system (PNS) manifestation of neuro-COVID [1]. The study is appealing but raises the following comments and concerns.
Downloads
Published
2021-05-21
Issue
Section
Articles
